Longevity spending is poised to explode. One stock to profit from the trend
PACCAR hitting all-time highs signals a booming U.S. economy. Senior living stocks are surging across the board. And Eli Lilly's GLP-1 drugs may be the closest thing to longevity medicine we've ever seen.
Read this issue
